埃索诺菲尔作为呼吸道病毒感染中的潜在生物标志物
Iole Macchia1, Valentina La Sorsa2, Francesca Urbani1
1Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Frontiers in immunology
|July 24, 2023
概括
埃索诺菲尔,关键的免疫细胞,在病毒感染和过敏性疾病中起着双重作用. 它们在血液中的水平可以预测COVID-19的严重程度,低数量表明更糟糕的结果,高数量表明更好的预后.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 乙氨基酸是对抗寄生虫和喘等过敏状况的免疫反应不可或缺的粒细胞.
- 它们还促进抗病毒免疫力,释放效应分子和细胞因子.
- 呼吸系统病毒与喘恶化有关,突出显示复杂的免疫相互作用.
研究的目的:
- 审查埃索诺菲尔在呼吸道病毒感染中的多方面的作用.
- 探索埃索诺菲尔作为潜在的生物标志物,用于诊断和预测病毒性疾病的严重程度,特别是COVID-19.
- 讨论在各种病理上下文中分析埃索诺菲尔子集的方法.
主要方法:
- 文献综述,重点关注病毒感染和过敏伴随性疾病中的乙氨基基基功能.
- 分析新出现的证据,以埃索诺菲尔作为生物标志物在SARS-CoV-2感染.
- 讨论用于表征乙氨基酸子集的技术.
主要成果:
- 乙氨基酸表现出抗病毒特性,并调节与Th2相关的炎症.
- 在COVID-19患者中,乙氨症与疾病严重程度相关.
- 在COVID-19中,乙氨基细胞数量的增加与预后改善和死亡率降低有关.
结论:
- 乙酸蛋白具有显著的可塑性,在病毒性和过敏性呼吸道疾病中起着复杂的作用.
- 乙氨基细胞计数显示为COVID-19预后的预测生物标志物具有前景.
- 对乙氨基基基子集的进一步研究可以完善它们作为诊断和预后工具的实用性.
更多相关视频
11:54Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
30.5K
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
7.9K
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K